Kissei Pharmaceutical Company Limited operates within the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Kissei Pharmaceutical Company Limited with three other
companies in this sector in Japan:
Daito Pharmaceutical Company Limited
sales of 37.98 billion Japanese Yen [US$340.72 million]
of which 59%
was Drug Substance),
JCR Pharmaceuticals Co., Ltd.
(18.09 billion Japanese Yen [US$162.22 million]
of which 98%
was Pharmaceutical Business), and
Fuji Pharma Company Limited
(35.39 billion Japanese Yen [US$317.42 million]
of which 100%
was Pharmaceutical Business).
During the year ended March of 2017, sales at
Kissei Pharmaceutical Company Limited were ¥71.71 billion (US$643.20 million).
a very small
increase of 0.6%
versus 2016, when the company's sales were ¥71.29 billion.
Sales of Other saw an increase
that was more than double the company's growth rate: sales were up
8.2% in 2017, from
¥9.47 billion to ¥10.25 billion.
Not all segments of Kissei Pharmaceutical Company Limited experienced an increase in sales in 2017:
sales of Pharmaceutical Products fell 0.6% to ¥61.45 billion.